Outcomes of Treatment-Resistant Neovascular Age-Related Macular Degeneration Switched from Aflibercept to Faricimab
Ophthalmology Retina · 2024-06 · 8 (6) · 537-544
DOI: 10.1016/j.oret.2023.11.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ophthalmology Retina, 2024-06. Verfasst von Raffaele Raimondi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sunderland Eye Infirmary, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, United Kingdom. Electronic address: raffor9@gmail.com. Hauptthemen laut MEDLINE: Receptors, Vascular Endothelial Growth Factor, Recombinant Fusion Proteins, Intravitreal Injections, Visual Acuity. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Roche, Bayer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sunderland Eye Infirmary, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, United Kingdom. Electronic address: raffor9@gmail.com.
- Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada; The Institute of Health Policy, Management and Evaluation (IHPME), Dalla Lana School of Public Health, University of Toronto, Toro…
- Sunderland Eye Infirmary, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, United Kingdom.
- Sunderland Eye Infirmary, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, United Kingdom; Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
Förderung
- Roche
- Bayer
Zitieren
APA
Raimondi, R., Felfeli, T., Bogdanova-Bennet, A., Varma, D., Habib, M., Kotagiri, A., Steel, D. H., & Grinton, M. (2024). Outcomes of Treatment-Resistant Neovascular Age-Related Macular Degeneration Switched from Aflibercept to Faricimab. Ophthalmology Retina, 8(6), 537-544. https://doi.org/10.1016/j.oret.2023.11.015
Vancouver
Raimondi R, Felfeli T, Bogdanova-Bennet A, Varma D, Habib M, Kotagiri A, et al. Outcomes of Treatment-Resistant Neovascular Age-Related Macular Degeneration Switched from Aflibercept to Faricimab. Ophthalmology Retina. 2024;8(6):537-544. doi:10.1016/j.oret.2023.11.015
BibTeX
@article{Raimondi2024,
author = {Raimondi, Raffaele and Felfeli, Tina and Bogdanova-Bennet, Anna and Varma, Deepali and Habib, Maged and Kotagiri, Ajay and Steel, David H and Grinton, Michael},
title = {Outcomes of Treatment-Resistant Neovascular Age-Related Macular Degeneration Switched from Aflibercept to Faricimab},
journal = {Ophthalmology Retina},
year = {2024},
volume = {8},
number = {6},
pages = {537--544},
doi = {10.1016/j.oret.2023.11.015}
}
EUVIMED